In patients with optic neuropathy of vascular origin, a regimen of transcranial magnetic electrical stimulation, Semax endonasal electrophoresis, oxybaric chamber and acupuncture reached therapeutic efficacy of 94% one week after treatment, against no more than 30-42% with basic vitamin therapy.
In plain wordsIn people with vascular optic nerve disease, a combined treatment that included Semax gave 94% efficacy at one week, against 30-42% or less with vitamins.
- Peptide
- Semax
- Outcome
- IncreaseTherapeutic efficacy 1 week after treatment
- Study
n = 60
- Comparator
- Basic therapy with vitamin complex (BEROCCA)
- Outcome group
- Vision and retina · Eye
Measurements
- Therapeutic efficacy
- 94%
- main group, 1 week after treatment
Source sentences
When evaluating the results in patients of the main group who received complex neurostimulation, the therapeutic efficacy in a week after the end of treatment was 94%, in 12 weeks - in 88% and in 24 weeks - 83%, while in patients of the control group for all studied indicators showed only a positive…
2 context sentences(design, population, supporting numbers)
The study included 60 patients (120 eyes) with a verified diagnosis of optic neuropathy of vascular origin, who were divided into 2 groups comparable in age, gender and anatomical and functional characteristics: the main group of 30 patients (60 eyes) and the control group - 30 patients (60 eyes), i…
Patients of the main group used a set of procedures: transcranial magnetic electrical stimulation, endonasal electrophoresis with the drug neuroprotector Semax 0.1%, oxybaric chamber and acupuncture.
In this study, Semax was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semax.